Edition:
India

Bio Rad Laboratories Inc (BIOb.N)

BIOb.N on New York Stock Exchange

257.95USD
6 Nov 2017
Change (% chg)

-- (--)
Prev Close
$257.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
258
52-wk High
$257.95
52-wk Low
$182.65

Chart for

About

Bio-Rad Laboratories, Inc. (Bio-Rad) is a manufacturer and distributor of its life science research and clinical diagnostics products. The Company operates through two segments: Life Science and Clinical Diagnostics. It manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a... (more)

Overall

Beta: 0.89
Market Cap(Mil.): $6,701.81
Shares Outstanding(Mil.): 29.58
Dividend: --
Yield (%): --

Financials

BRIEF-Bio-Rad Authorizes New $250 Million Share Repurchase Program

* BIO-RAD AUTHORIZES NEW $250 MILLION SHARE REPURCHASE PROGRAM

28 Nov 2017

BRIEF-Bio Rad Laboratories reports Q3 earnings per share $0.91

* Bio Rad Laboratories Inc reports third-quarter 2017 financial results

03 Nov 2017

BRIEF-U.S. ITC to probe certain 10X Genomics devices after Bio-Rad complaint

* U.S. U.S. International Trade Commission says it will investigate certain microfluidic devices by 10x Genomics Inc after complaint by Bio-rad Laboratories Inc and Lawrence Livermore National Security LLC. Source text for Eikon: Further company coverage: (Reporting By Susan Heavey)

31 Aug 2017

BRIEF-Bio-Rad reports Q2 earnings per share $0.17

* Q2 earnings per share view $0.56 -- Thomson Reuters I/B/E/S

04 Aug 2017

Earnings vs. Estimates